Discussion: View Thread

Discovery of Functional Antibody Leads at Early Stage of Lead Screening

  • 1.  Discovery of Functional Antibody Leads at Early Stage of Lead Screening

    Posted 11-02-2025 07:11 PM
      |   view attached

    Currently, most therapeutic antibody discovery strategies start by binder screening, followed by purification of these antibodies for further functional characterization. However, massive resources are invested into the time-consuming step-by-step screening schema, and arbitrary selection of candidates purely based on binding capability further compromises diversity.

    In this technical manual, there will be solutions that can be applied to current antibody discovery platforms to overcome this issue and significantly improve process efficiency.



    ------------------------------
    Jessica Tu
    Regional Marketing Manager
    ProBio
    ------------------------------